11 related news articles for Lung cancer
Combatting a killer – understanding what causes small cell lung cancer
A new understanding of the causes of small cell lung cancer (SCLC) could lead to more personalised treatments and lower mortality from this deadly disease.… Read more
Hudson Institute 2021 Emerging Leaders announced
Six Early Career Researchers have been chosen for the 2021 Hudson Institute Emerging Leaders program.… Read more
Link between COPD, emphysema and lung cancer could lead to new treatments
Hudson Institute scientists have paved the way to potentially test new treatments for chronic obstructive pulmonary disease (COPD) and emphysema, following a discovery of the molecular drivers of these lung diseases.… Read more
Cancer Council Victoria Postdoctoral Fellowship awarded to progress lung cancer research
Congratulations to Dr Mohamed Saad, who has been awarded a Cancer Council Victoria (CCV) Postdoctoral Cancer Research Fellowship to inform the design of better treatment approaches in lung cancer.… Read more
Mid-career researcher recognised by the Victorian Cancer Agency
Congratulations to Dr Daniel Gough for receiving a Mid-Career Research Fellowship from the Victorian Cancer Agency (VCA) for his research in developing new therapies for small cell lung cancer (SCLC).… Read more
Mistaken identity: new mechanism behind stomach cancer identified
Improved treatments for a range of cancers could be possible following a discovery that stomach cancer is mainly driven by a different process than previously believed.… Read more
Drug may be breakthrough to treat lung cancer
The development of a drug to treat the most common type of lung cancer is a step closer … Read more
Turbo-charging chemotherapy for lung cancer
A naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer, according to new findings from Sydney and Melbourne researchers. And the hormone – known as follistatin – also appears to prevent kidney damage, a serious side effect of chemotherapy. The promising new ‘two birds, one stone’ treatment approach, which was… Read more
Researchers identify key driver of devastating muscle wasting disease affecting cancer patients
Lung cancer is the leading cause of cancer death worldwide, and is frequently associated with cachexia. Cachexia is a devastating syndrome of weight and muscle wasting, affecting as many as 80 per cent of advanced cancer patients.… Read more
International ICI delegates tour Monash Health Translation Precinct
Scientists from across the world discussing immunology research… Read more
Double blow for lung cancer and emphysema offers hope to patients
Lung cancer and emphysema could be diagnosed earlier and targeted with an existing drug, vastly improving patient outcomes, researchers at Hudson Institute of Medical Research have discovered… Read more